5.07
Aspire Biopharma Holdings Inc Aktie (ASBP) Neueste Nachrichten
Aspire Biopharma Company Profile & Introduction - Moomoo
Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack - The Augusta Chronicle
Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements - The Destin Log
ASBP Stock Price, Quote & Chart | ASPIRE BIOPHARMA HOLDINGS IN (NASDAQ:ASBP) - ChartMill
Why Kulicke And Soffa Industries Shares Are Trading Higher By 19%; Here Are 20 Stocks Moving Premarket - Sahm
ASBP Financials: Income Statement, Balance Sheet & Cash Flow | Aspire Biopharma Holdings Inc - Stock Titan
Aspire Biopharma Holdings, Inc. 1Q 2026: Revenue $28.35K, Net loss $(3.22M), EPS $(20.57) — 10-Q Summary - TradingView
Aspire Biopharma Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Aspire Biopharma Announces 1-for-30 Reverse Stock Split - TipRanks
Aspire Biopharma (ASBP) Authorizes $5M Share Repurchase Program - Insider Monkey
Ardsley-related holders report ≤5% in Aspire Biopharma (ASBP) - Stock Titan
Aspire Biopharma (ASBP) asks shareholders to approve pre-funded warrants and share adjustments - Stock Titan
TradingKey - TradingKey
ASBP Stock Jumps 21% On Buyback Offer – Retail Believes Every Dip’s A Buying Opportunity - MSN
Warrant and dilution approvals on agenda at Aspire Biopharma (ASBP) - Stock Titan
Aspire Biopharma Holdings, Inc. Announces Approval Of Reverse Stock Split Ratio - ACCESS Newswire
Sublingual Drug Reformulator Expands into Caffine Market & Gets Capital Injection - Streetwise Reports
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Sahm
12 Health Care Stocks Moving In Thursday's Intraday Session - Sahm
4 High Volatility Penny Stocks Technical Analysis | ASBP, OCG, GPUS & LUCY Stock Forecast (j9FZjuwfde) - Fathom Journal
Aspire Biopharma's Buzz Bomb(TM) Caffeine Company's Brand Ambassador, Ashley Paulson, to Attempt Fastest 100-Mile Treadmill Run at 2026 Boston Marathon Expo - ACCESS Newswire
Nasdaq compliance push: Aspire Biopharma enacts 1-for-30 split - Stock Titan
These stocks are the most active in today's session - ChartMill
Aspire Biopharma Has Entered Into a Letter of Intent to Acquire a Leading Global Automotive Supplier With a 100+ Year History and $200M+ in 2025 Revenue - ACCESS Newswire
Aspire Biopharma to implement 1-for-30 reverse stock split By Investing.com - Investing.com Nigeria
Aspire Biopharma to implement 1-for-30 reverse stock split - Investing.com
Aspire Biopharma Holdings, Inc. Announces Reverse Stock Split Approval - geneonline.com
Why Qualcomm Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Sahm
ASBP: A Platform Approach to Drug Delivery with an Unconventional Path to Commercialization - Zacks Small Cap Research
ASBP - Finviz
LCID, ASBP, WLDS stocks hit 52-week lows: What drove the selloff? - MSN
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
ASBP bulls back in control after 78% crash: What changed? - MSN
Aspire Biopharma announces $5M share repurchase program - MSN
Aspire Biopharma regains Nasdaq minimum bid price compliance - MSN
Aspire Biopharma (ASBP) asks holders to approve warrants, $0.00001 exercise price - Stock Titan
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):